Cholesterol Test Market Expands with Advanced Diagnostics and Integration with Digital Health, CAGR Expected at 8.20%

The Cholesterol Test Market has witnessed significant growth in recent years, driven by increasing awareness about cardiovascular health and the rising prevalence of lifestyle-related diseases. Cholesterol testing plays a crucial role in assessing an individual's risk for heart diseases, making it a vital component of preventive healthcare.

The cholesterol test market is expected to reach USD 11.6 billion by 2032 at 8.20% CAGR during the forecast period 2023-2032

Cholesterol testing products and services have become indispensable tools in managing and monitoring cholesterol levels. The market is characterized by a diverse range of cholesterol testing products, including cholesterol test strips, cholesterol test kits, and cholesterol meters. These products offer convenient and efficient ways for individuals to monitor their cholesterol levels at home, enabling proactive management of cardiovascular health.

Cholesterol testing services have also experienced a surge in demand, with healthcare providers offering comprehensive cholesterol testing as part of routine check-ups. These services often include lipid profile assessments, which measure levels of various cholesterol components such as LDL (low-density lipoprotein), HDL (high-density lipoprotein), and total cholesterol. This detailed analysis provides a more holistic understanding of an individual's cardiovascular risk.

The increasing prevalence of sedentary lifestyles, unhealthy dietary habits, and obesity has fueled the demand for cholesterol testing products and services. As a result, the market has witnessed a steady influx of innovative technologies and solutions aimed at enhancing the accuracy and accessibility of cholesterol testing.

Major Key Players:

Some of the Cholesterol Test Companies are Quest Diagnostics Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo Fisher Scientific, PTS DIAGNOSTICS, Alere Inc., F. Hoffmann-La Roche AG, and Eurofins Scientific.

Segment Analysis

The Global Cholesterol Test Market has been segmented based on Product Type, Test Type, Distribution Channel, and End User. 

The point of care cholesterol testing market, based on product type, has been divided into cholesterol levels test kits and test strips. The test kits segment is likely to be the largest segment during the review period due to the growing awareness and adoption of preventive healthcare.

The market, based on test type, has been divided into total cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides/VLDL cholesterol test. The total cholesterol test segment is likely to be the largest segment during the review period due to the growing importance of the test. A complete cholesterol test includes the calculation of four types of fats (lipids) in blood.

The market, based on distribution channel, has been divided into over the counter and prescription-based. The prescription-based segment is likely to be the largest segment during the review period.  

The global cholesterol test market has been segmented, based on end user, into hospitals & clinics, homecare, diagnostic centers, and others. The hospitals & clinics segment is expected to hold the majority share of the market owing to the rising in visits of patients in the hospitals and clinics.

Recent Development

Nov 2023 Subcutaneous, or under the skin, Tecentriq® (atezolizumab) has been recommended for clearance by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), according to a statement from Roche. In contrast to intravenous (IV) infusions, which can take 30 to 60 minutes, Tecentriq SC injections can be completed in around seven minutes, with most injections taking four to eight minutes. This can free significant time for patients, medical professionals, and caregivers. For all indications for which Tecentriq IV has previously been approved, including specific forms of liver, breast, lung, and bladder cancer, the CHMP advised using Tecentriq SC. The European Commission is anticipated to make a final judgment regarding its approval shortly.

Nov 2023 To promote colorectal cancer screening in the US, in which over 110 million people may be eligible, Quest Diagnostics Incorporated DGX and Universal DX entered a strategic partnership. Colorectal cancer ranks third in terms of cancer diagnoses in the US and is the third leading cause of cancer-related deaths in both men and women. The most recent action will strengthen Quest Diagnostics' Diagnostic Solutions division by broadening its offering of cancer services.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The cholesterol test market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. As per recent studies, most (55.4%) of the Canadian adult population categorized as overweight (34.2%) or obese (21.2%). Furthermore, the prevalence of obese classes I, II, and III will increase to 14.8%, 4.4% and 2.0%, respectively.

The European cholesterol test market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. According to WHO, the obesity rate in Germany is 23.7% which means that Germany has one of the highest obesity rates in Europe, but is still behind the UK, which has a rate of 26.2 %.

The cholesterol test market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of cardiovascular diseases and obesity, the market in Asia-Pacific is expected to be the fastest-growing. According to WHO, Obesity in China is a major health concern with overall rates of obesity between 5% and 6% for the country, but greater than 20% in some cities where fast food is popular. The cholesterol test market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Related Reports:

Sleeping Bruxism Treatment Market

Artificial Insemination Market

Orthodontic Supplies Market

Molecular Diagnostics Market

Menopause Treatment Market

Artificial Intelligence in Healthcare Market

For More Information, Please Visit @ Market Research Future

Comments

Post a Comment

Popular posts from this blog

Nanobody Market Expected to Reach 2.94 billion by 2032, Driven by Superior Targeting and Efficacy

  According to MRFR analysis, the global  nanobody market  is expected to register a CAGR of 17.88% from 2023 to 2032 and hold a value of over USD 2.94 billion by 2032 In recent years, the field of biotechnology has witnessed a transformative breakthrough with the advent of nanobodies and Nanobody technology. Nanobodies, also known as VHH antibodies or single-domain antibodies, are small antigen-binding fragments derived from camelid heavy-chain antibodies. Their unique properties have positioned them as powerful tools in various applications, ranging from therapeutic drug development to diagnostics and imaging. Nanobody technology harnesses the potential of these small, robust antibody fragments. Unlike traditional antibodies, nanobodies are compact, stable, and exhibit superior tissue penetration, making them ideal candidates for therapeutic interventions. Their single-domain structure allows for precise targeting of specific antigens, minimizing off-target effects and ...
Read more

US Physician Groups Market Growth with a CAGR of 5.80% to Reach USD 524.1 Billion by 2032

  The  US Physician Groups Market  is expected to reach USD 524.1 Billion by 2032 at 5.80% CAGR during the forecast period 2023-2032. The US Physician Groups market is a dynamic and essential component of the country's healthcare system, comprising a diverse range of medical professionals dedicated to providing primary care services. Among these healthcare providers, the role of the family physician stands out prominently. Family doctors play a pivotal role in delivering comprehensive healthcare to individuals and families, acting as primary points of contact for a wide array of medical concerns. Physician groups in the United States have evolved to meet the growing demand for accessible and personalized healthcare. The emphasis on preventive care and holistic well-being has elevated the significance of family physicians within these groups. These healthcare professionals are trained to address a broad spectrum of medical issues, from routine check-ups to managi...
Read more

Wound Dressings Devices Market, Projected to Grow at a CAGR of 5% and Reach USD 11.63 Billion by 2032

The  Wound Dressings Devices Market  is expected to reach USD 11.63 Billion by 2032 at 5 % CAGR during the forecast period 2023-2032. The global Wound Dressings Devices Market is experiencing significant growth, driven by the increasing prevalence of chronic wounds and a rising aging population. Wound dressings play a crucial role in wound care, promoting healing and preventing infections. As the demand for advanced wound care solutions continues to rise, the market for wound dressing devices is expected to witness steady expansion. Wound dressings  are essential components in the management of various types of wounds, including surgical wounds, diabetic ulcers, and traumatic injuries. The emphasis on effective wound care has led to the development of innovative dressing materials and devices that accelerate the healing process. These devices not only provide a protective barrier against external contaminants but also create an optimal environment for tissue regeneration....
Read more